Description
SEMAX/SELANK is a research-focused peptide formulation that merges two complementary neuropeptides: Semax (a synthetic ACTH 4-10 analogue) and Selank (a Tuftsin-derived heptapeptide). This combination is studied for its synergistic effects on cognition, memory, stress adaptation, and emotional regulation.
Mechanism of Action
-
Semax: Enhances dopaminergic signaling and BDNF-mediated neuroplasticity, supporting memory, learning, focus, and cerebral metabolism
-
Selank: Provides anxiolytic effects and modulates serotonin turnover, reducing stress-induced overactivation of the limbic system
-
Together, they promote cognitive performance, emotional stability, and resilience to stress
Dosage Guidelines (Research Use)
-
Cognitive Enhancement: 500 mcg–1 mg per day, often divided into two doses
-
Treatment of Ischemic Stroke (research models): 1 mg four times daily for up to 10 days
-
Administration: Intranasal spray is common to ensure CNS bioavailability (~30 min onset)
-
Cycle Length: Determined by experimental protocol; start low and titrate based on tolerance and response
Important Notes
-
Designed for research purposes only; not for human or animal consumption
-
Effects may vary between subjects and experimental conditions
-
Dosage frequency and size should be tailored to study requirements
Useful Information
-
Class: Dual neuropeptide nootropic / stress-regulation complex
-
Primary Research Focus: Cognitive enhancement, memory consolidation, stress adaptation, mood stabilization



Reviews
There are no reviews yet.